A Scoping Review of Factors that Influence Opioid Overdose Prevention for Justice-Involved Populations

Grella, C.E., Ostlie, E., Scott, C.K. et al. A scoping review of factors that influence opioid overdose prevention for justice-involved populations. Subst Abuse Treat Prev Policy 16, 19 (2021). https://doi.org/10.1186/s13011-021-00346-1
Publication Date



There is a high risk of death from opioid overdose following release from prison. Efforts to develop and implement overdose prevention programs for justice-involved populations have increased in recent years. An understanding of the gaps in knowledge on prevention interventions is needed to accelerate development, implementation, and dissemination of effective strategies.

High Risk Substance Use and Overdose Among Youth Conference


The rising numbers of young people with high-risk substance use, especially suffering from overdose, is alarming. Adolescence and young adulthood (under the age of 25) is the period of highest incidence and greatest impact of mental health and substance use disorders, yet there are no youth-specific services in place.

Could a Telehealth Programme Improve Outcomes for Justice-Involved Women?

Evidence has shown that individuals released from prison are at greater risk of drug overdose in the first 2 weeks post-release compared to the general population. After a period of relative abstinence, the tolerance of people who use opioids is greatly reduced and, as a result, they are at particularly high risk of overdosing if they resume use. In order to support this particularly vulnerable group of people, the National Institute of Health is developing

Opioid Overdose Reversal with Naloxone (Narcan, Evzio)

Created by
Publication Date

What is Naloxone?

Naloxone is a medication designed to rapidly reverse opioid overdose. It is an opioid antagonist—meaning that it binds to opioid receptors and can reverse and block the effects of other opioids. It can very quickly restore normal respiration to a person whose breathing has slowed or stopped as a result of overdosing with heroin or prescription opioid pain medications. 

Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults

Nguyen AP, Glanz JM, Narwaney KJ, Binswanger IA. Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults. JAMA Netw Open. 2020;3(3):e201018. doi:10.1001/jamanetworkopen.2020.1018
Publication Date


Importance: Family members are cited as a common source of prescription opioids used for nonmedical reasons. However, the overdose risk associated with exposure to opioids prescribed to family members among adolescents and young adults is not well established.

Outreach to People Who Survive Opioid Overdose

Langabeer, J., Champagne-Langabeer, T., Luber, S. D., Prater, S. J., Stotts, A., Kirages, K., ... & Chambers, K. A. (2020). Outreach to people who survive opioid overdose: Linkage and retention in treatment. Journal of Substance Abuse Treatment, 111, 11-15.

Often it takes a critical moment, such as when someone survives an overdose, to motivate behavioural change.

It is particularly important that at these times people have access to the appropriate treatment.

Free Webinar: Opioid Agonist Treatment for Pharmaceutical Opioid Dependence


Turning Point will be offering a free webinar Tuesday 3rd March 2020 at 8:30 AM ACST

This session aims to briefly cover the main opioid agonist pharmacotherapies for opioid dependence, and summarise the evidence for the use of these treatments for pharmaceutical opioid dependence.

How to Integrate Medication-Assisted Treatment within the Healthcare Delivery System


Medication can enhance recovery and prevent overdose when it is coupled with other behavioural health interventions that focus on substance use disorders and addiction.

Join the Center of Excellence for Integrated Health Solutions to discover what medication-assisted treatment is, identify when to implement it, and how to successfully integrate it into recovery care plans.

July 2nd, 2 pm Eastern Time (ET)